Proposal to list medical devices supplied by Jackson Allison Medical & Surgical Limited

Hospital devices Consultation Closed

Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.

What we’re proposing

Pharmac is seeking feedback on a proposal to list medical devices supplied by Jackson Allison Medical & Surgical Limited (“Jackson Allison”) in Part III of Section H of the Pharmaceutical Schedule from 1 September 2022 through a non-exclusive provisional agreement.

We propose to list medical devices in the following categories:

Consultation closes at 4pm Friday 5 August 2022 and feedback can be emailed to

What would the effect be?

From 1 September 2022, medical devices supplied by Jackson Allison would be listed under a proposed national agreement (“Agreement”) that all Te Whatu Ora Hospitals may purchase under, subject to consultation and approval by Pharmac’s Board or delegate.

The Agreement would not be for sole supply and Te Whatu Ora Hospitals can continue to purchase other suppliers’ brands of electrocardiogram equipment and accessories and patient assessment, monitoring and treatment devices.

The Agreement would supersede any existing Te Whatu Ora Hospitals agreements with Jackson Allison for the medical devices included in the Agreement. Any medical device listed in the Agreement and purchased by a Te Whatu Ora Hospital would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing in the Pharmaceutical Schedule.

Pricing for the equipment and accessories in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.

Who we think will be interested

  • Te Whatu Ora Hospital staff including but not limited to:
    • Clinical Engineers and Maintenance Services
    • Clinical Product Evaluators
    • Cardiologists
    • Cardiac Physiologists and Perfusionists
    • Maternity Care Specialists
    • Wards and outpatient clinics
    • Patient Monitoring
    • Nurses
    • Procurement Officers and Supply Chain Personnel
  • Suppliers and wholesalers

About the medical devices

Electrocardiogram equipment and accessories

The electrocardiogram equipment and accessories category includes medical devices used to collect, measure and interpret the electrical activity of the heart. This includes electrocardiogram monitors, holter monitors and associated accessories (such as gels, electrodes and leads).

Patient assessment, monitoring and treatment

Patient assessment, monitoring and treatment devices include equipment and consumable medical devices that are used in a variety of clinical settings to assess, monitor and treat patients.

Clinical areas of use include Audiology, Ear, Nose and Throat (ENT), Dermatology, Gastroenterology, Neurosciences and Psychology, Ophthalmology, Somnology, Urology, Vascular Medicine, Wards and Outpatient Clinics.

Why we’re proposing this

Pharmac has previously released Registrations of Interest (ROI)/Requests for Proposal (RFP) for non-exclusive national agreements for listing on the Pharmaceutical Schedule:

Pharmac has been working with suppliers who responded to these processes to seek provisional agreements. This proposal is the latest to arise from these processes and we expect to consult on further provisional agreements with suppliers in this category throughout 2022.

Details about our proposal

Pharmac has entered into a provisional agreement with Jackson Allison for the supply of the above medical devices.

The proposal would result in Pharmaceutical Schedule listings for:



Number of devices

Electrocardiogram equipment and accessories

  • Aquasonic
  • Leonhard Lang
  • Nissha
  • Sonipac


Patient assessment, monitoring and treatment devices

  • Evexar
  • Ivalon
  • Qingdao
  • Sapimed
  • Sutherland


Further information, including pricing and contractual details, has been provided to Te Whatu Ora Hospital’s procurement personnel. Clinicians interested in further detail on what this change means for their hospital should engage with their procurement teams.

To provide feedback

Send us an email: by 4pm 5 August 2022.

All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.

Your feedback may be shared

Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.

We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.